Guardant Health, Inc.
GH
$54.90
-$1.90-3.35%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | -413.82M | -416.55M | -436.37M | -512.41M | -490.76M |
Total Depreciation and Amortization | 41.33M | 41.91M | 42.39M | 42.80M | 43.24M |
Total Amortization of Deferred Charges | 1.29M | 1.29M | 1.29M | 1.29M | 1.29M |
Total Other Non-Cash Items | 191.26M | 193.15M | 213.70M | 208.11M | 155.48M |
Change in Net Operating Assets | -58.61M | -92.07M | -60.86M | 6.14M | 9.95M |
Cash from Operations | -238.55M | -272.26M | -239.86M | -254.07M | -280.81M |
Capital Expenditure | -33.18M | -32.61M | -35.09M | -20.29M | -18.46M |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 41.10M | 46.10M | -226.22M | 411.90M | 965.60M |
Cash from Investing | 7.92M | 13.49M | -261.31M | 391.62M | 947.14M |
Total Debt Issued | 0.00 | 5.03M | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | 15.05M | 15.39M | 14.84M | 104.00M | 104.05M |
Repurchase of Common Stock | -78.83M | -74.64M | -15.68M | -10.74M | -10.87M |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -7.28M | -12.55M | -153.00K | -747.00K | 6.02M |
Cash from Financing | -71.05M | -66.77M | -996.00K | 92.51M | 99.20M |
Foreign Exchange rate Adjustments | 1.92M | 141.00K | -1.77M | 955.00K | -1.47M |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -299.76M | -325.40M | -503.93M | 231.01M | 764.07M |